Evidence map›Paper›PMID 35028801›Full record

ArticleJournal of clinical immunology2022

Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency.

Naz Surucu Yilmaz, Sevgi Bilgic Eltan, Basak Kayaoglu, Busranur Geckin, Raul Jimenez Heredia, Asena Pinar Sefer, Ayca Kiykim, Ercan Nain, Nurhan Kasap, Omer Dogru and 17 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 4 countries.

Naz Surucu Yilmaz *Department of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Sevgi Bilgic Eltan *Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Basak Kayaoglu *Department of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Busranur GeckinDepartment of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Raul Jimenez HerediaLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Asena Pinar SeferDivision of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Ayca KiykimFaculty of Medicine, Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Ercan NainDivision of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Nurhan KasapDivision of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Omer DogruDivision of Pediatric Hematology-Oncology, Marmara University, Istanbul, Turkey.
Ayse Deniz YuceltenDivision of Dermatology, Marmara University, Istanbul, Turkey.
Leyla CinelDivision of Pathology, Marmara University, Istanbul, Turkey.
Gulsun KarasuGoztepe Medicalpark Hospital, Pediatric Stem Cell Transplantation Unit, İstanbul, Turkey.
Akif YesilipekGoztepe Medicalpark Hospital, Pediatric Stem Cell Transplantation Unit, İstanbul, Turkey.
Betul SozeriDivision of Pediatric Rheumatology, University of Health Sciences, Umraniye Research and Training Hospital, Istanbul, Turkey.
Goksu Gokberk KayaTherapeutic ODN Research Lab, Department of Molecular Biology and Genetics, Bilkent University, Bilkent, 06800, Ankara, Turkey.
Ismail Cem YilmazDepartment of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Ilayda BaydemirDepartment of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Yagmur AydinDepartment of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey.
Deniz Cansen KahramanKanSiL, Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey.
Matthias HaimelLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Kaan BoztugLudwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.
Elif Karakoc-AydinerDivision of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Ihsan GurselTherapeutic ODN Research Lab, Department of Molecular Biology and Genetics, Bilkent University, Bilkent, 06800, Ankara, Turkey.
Ahmet OzenDivision of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey.
Safa Baris *Division of Pediatric Allergy and Immunology, Marmara University, Fevzi Çakmak Mah. No: 41, Istanbul, Turkey. safabaris@hotmail.com.
Mayda Gursel *Department of Biological Sciences, Middle East Technical University, B-58, Üniversiteler Mah. Dumlupınar Bulvarı No:1, Ankara, Turkey. mgursel@metu.edu.tr.ORCID 0000-0003-0044-9054
Marmara University · TRMiddle East Technical University · TRAustrian Academy of Sciences · ATBilkent University · TRIstanbul Eye Hospital · TRCenter for Translational Molecular Medicine · NLIstanbul University-Cerrahpaşa · TRÜmraniye Eğitim ve Araştırma Hastanesi · TR

Funding

Türkiye Bilimsel ve Teknolojik Araştirma Kurumu 318S202
6 · The paper itself

Abstract

NF-κB essential modulator (NEMO, IKK-γ) deficiency is a rare combined immunodeficiency caused by mutations in the IKBKG gene. Conventionally, patients are afflicted with life threatening recurrent microbial infections. Paradoxically, the spectrum of clinical manifestations includes severe inflammatory disorders. The mechanisms leading to autoinflammation in NEMO deficiency are currently unknown. Herein, we sought to investigate the underlying mechanisms of clinical autoinflammatory manifestations in a 12-years old male NEMO deficiency (EDA-ID, OMIM #300,291) patient by comparing the immune profile of the patient before and after hematopoietic stem cell transplantation (HSCT). Response to NF-kB activators were measured by cytokine ELISA. Neutrophil and low-density granulocyte (LDG) populations were analyzed by flow cytometry. Peripheral blood mononuclear cells (PBMC) transcriptome before and after HSCT and transcriptome of sorted normal-density neutrophils and LDGs were determined using the NanoString nCounter gene expression panels. ISG15 expression and protein ISGylation was based on Immunoblotting. Consistent with the immune deficiency, PBMCs of the patient were unresponsive to toll-like and T cell receptor-activators. Paradoxically, LDGs comprised 35% of patient PBMCs and elevated expression of genes such as MMP9, LTF, and LCN2 in the granulocytic lineage, high levels of IP-10 in the patient's plasma, spontaneous ISG15 expression and protein ISGylation indicative of a spontaneous type I interferon (IFN) signature were observed, all of which normalized after HSCT. Collectively, our results suggest that type I IFN signature observed in the patient, dysregulated LDGs and spontaneously activated neutrophils, potentially contribute to tissue damage in NEMO deficiency.

Indexed as

Ectodermal DysplasiaNeutrophilsChildGranulocytesHumansI-kappa B KinaseLeukocytes, MononuclearMaleI-kappa B KinaseIKBKG protein, humanAutoinflammationInterferon stimulated genes (ISGs)Low-density granulocytesNEMO deficiencyNeutrophil activation related genes

Identifiers

PMID35028801
OpenAlexW4206471787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.